GlassScriptPhysician profile
Sequita Richardson
NPI 1356312458
$3,373.18
in general payments reported to CMS, 2019-2025
17 companies · $611 in 2025
The $611 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $356 · 2020: $124 · 2021: $235 · 2022: $519 · 2023: $683 · 2024: $845 · 2025: $611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,138.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,380.61 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Novo Nordisk INC | $369.73 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Teva Pharmaceuticals USA, INC. | $349.22 | 2022-2023 | Austedo Xr, Uzedy |
| Amarin Pharma, INC. | $245.44 | 2019-2020 | |
| Glaxosmithkline, LLC. | $201.75 | 2021-2025 | |
| Medtronic, INC. | $149.17 | 2022-2025 | Inceptiv |
| Exact Sciences Corporation | $125.53 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Radius Health, INC. | $122.09 | 2019 | |
| Astellas Pharma US INC | $112.35 | 2019 | |
| Averitas Pharma INC. | $102.80 | 2024-2025 | Qutenza |
| Amgen INC. | $71.66 | 2024 | Tezspire |
| Gilead Sciences, INC. | $39.68 | 2025 | |
| Electromed, INC. | $22.57 | 2024 | Smartvest |
| Xeris Pharmaceuticals, INC. | $22.51 | 2023 | Keveyis |
| Lilly USA, LLC | $21.37 | 2025 | Mounjaro, Zepbound |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $20.74 | 2025 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $15.96 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sequita Richardson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.